Lucid Historical Financial Ratios

LUCD Stock  USD 0.81  0.02  2.53%   
Lucid Diagnostics is lately reporting on over 94 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Invested Capital of 0.0 will help investors to properly organize and evaluate Lucid Diagnostics financial condition quickly.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lucid Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.

About Lucid Financial Ratios Analysis

Lucid DiagnosticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Lucid Diagnostics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Lucid financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Lucid Diagnostics history.

Lucid Diagnostics Financial Ratios Chart

At present, Lucid Diagnostics' Net Debt To EBITDA is projected to decrease significantly based on the last few years of reporting. The current year's Graham Number is expected to grow to 1.80, whereas Book Value Per Share is projected to grow to (0.05).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Dividend Yield

Dividend Yield is Lucid Diagnostics dividend as a percentage of Lucid Diagnostics stock price. Lucid Diagnostics dividend yield is a measure of Lucid Diagnostics stock productivity, which can be interpreted as interest rate earned on an Lucid Diagnostics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.
Most ratios from Lucid Diagnostics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Lucid Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lucid Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.At present, Lucid Diagnostics' Net Debt To EBITDA is projected to decrease significantly based on the last few years of reporting. The current year's Graham Number is expected to grow to 1.80, whereas Book Value Per Share is projected to grow to (0.05).
 2010 2022 2023 2024 (projected)
Payables Turnover0.393.425.225.48
Days Of Inventory On Hand307.611.2116.9716.12

Lucid Diagnostics fundamentals Correlations

-0.620.79-0.040.960.910.830.98-0.621.00.90.99-0.860.890.98-1.0-0.490.71-0.32-0.610.39-0.98-0.610.99-0.49-0.83
-0.62-0.430.39-0.69-0.82-0.45-0.641.0-0.63-0.83-0.530.61-0.81-0.640.610.68-0.340.651.0-0.370.591.0-0.640.970.4
0.79-0.430.110.670.640.70.71-0.430.770.630.83-0.540.590.7-0.8-0.350.86-0.19-0.44-0.08-0.86-0.440.72-0.42-0.88
-0.040.390.11-0.22-0.410.12-0.10.39-0.06-0.43-0.050.2-0.43-0.10.020.790.210.930.34-0.33-0.020.34-0.090.34-0.2
0.96-0.690.67-0.220.950.680.99-0.690.970.950.93-0.950.960.99-0.95-0.660.51-0.45-0.670.6-0.91-0.670.99-0.56-0.65
0.91-0.820.64-0.410.950.680.92-0.820.911.00.87-0.861.00.92-0.9-0.760.52-0.66-0.80.51-0.86-0.80.92-0.71-0.63
0.83-0.450.70.120.680.680.74-0.450.810.670.84-0.460.630.73-0.86-0.10.9-0.17-0.46-0.08-0.89-0.460.75-0.31-0.94
0.98-0.640.71-0.10.990.920.74-0.640.990.920.96-0.940.931.0-0.97-0.560.58-0.34-0.620.55-0.94-0.621.0-0.5-0.71
-0.621.0-0.430.39-0.69-0.82-0.45-0.64-0.63-0.83-0.530.61-0.81-0.640.610.68-0.340.651.0-0.370.591.0-0.640.970.4
1.0-0.630.77-0.060.970.910.810.99-0.630.910.98-0.890.910.99-0.99-0.510.67-0.33-0.620.44-0.97-0.620.99-0.49-0.79
0.9-0.830.63-0.430.951.00.670.92-0.830.910.86-0.861.00.92-0.89-0.770.51-0.67-0.80.52-0.85-0.80.92-0.71-0.62
0.99-0.530.83-0.050.930.870.840.96-0.530.980.86-0.820.850.96-0.99-0.470.76-0.31-0.520.31-0.99-0.520.96-0.39-0.86
-0.860.61-0.540.2-0.95-0.86-0.46-0.940.61-0.89-0.86-0.82-0.9-0.940.830.68-0.270.370.58-0.790.770.58-0.930.490.44
0.89-0.810.59-0.430.961.00.630.93-0.810.911.00.85-0.90.93-0.88-0.780.45-0.66-0.780.59-0.83-0.780.92-0.69-0.57
0.98-0.640.7-0.10.990.920.731.0-0.640.990.920.96-0.940.93-0.97-0.560.57-0.34-0.620.56-0.94-0.621.0-0.5-0.71
-1.00.61-0.80.02-0.95-0.9-0.86-0.970.61-0.99-0.89-0.990.83-0.88-0.970.46-0.750.30.61-0.340.990.61-0.980.480.85
-0.490.68-0.350.79-0.66-0.76-0.1-0.560.68-0.51-0.77-0.470.68-0.78-0.560.46-0.040.880.63-0.60.410.63-0.550.640.12
0.71-0.340.860.210.510.520.90.58-0.340.670.510.76-0.270.450.57-0.75-0.04-0.09-0.36-0.37-0.82-0.360.6-0.28-0.98
-0.320.65-0.190.93-0.45-0.66-0.17-0.340.65-0.33-0.67-0.310.37-0.66-0.340.30.88-0.090.61-0.290.280.61-0.340.610.11
-0.611.0-0.440.34-0.67-0.8-0.46-0.621.0-0.62-0.8-0.520.58-0.78-0.620.610.63-0.360.61-0.340.591.0-0.620.970.42
0.39-0.37-0.08-0.330.60.51-0.080.55-0.370.440.520.31-0.790.590.56-0.34-0.6-0.37-0.29-0.34-0.23-0.340.53-0.280.19
-0.980.59-0.86-0.02-0.91-0.86-0.89-0.940.59-0.97-0.85-0.990.77-0.83-0.940.990.41-0.820.280.59-0.230.59-0.950.470.91
-0.611.0-0.440.34-0.67-0.8-0.46-0.621.0-0.62-0.8-0.520.58-0.78-0.620.610.63-0.360.611.0-0.340.59-0.620.970.42
0.99-0.640.72-0.090.990.920.751.0-0.640.990.920.96-0.930.921.0-0.98-0.550.6-0.34-0.620.53-0.95-0.62-0.5-0.73
-0.490.97-0.420.34-0.56-0.71-0.31-0.50.97-0.49-0.71-0.390.49-0.69-0.50.480.64-0.280.610.97-0.280.470.97-0.50.32
-0.830.4-0.88-0.2-0.65-0.63-0.94-0.710.4-0.79-0.62-0.860.44-0.57-0.710.850.12-0.980.110.420.190.910.42-0.730.32
Click cells to compare fundamentals

Lucid Diagnostics Account Relationship Matchups

Lucid Diagnostics fundamentals Accounts

201920202021202220232024 (projected)
Ptb Ratio(81.94)(32.18)3.432.13(25.48)(26.75)
Book Value Per Share(0.14)(0.37)1.570.64(0.0553)(0.0526)
Free Cash Flow Yield(0.005428)(0.0129)(0.0988)(0.62)(0.56)(0.53)
Operating Cash Flow Per Share(0.0638)(0.15)(0.51)(0.82)(0.79)(0.83)
Pb Ratio(81.94)(32.18)3.432.13(25.48)(26.75)
Free Cash Flow Per Share(0.0638)(0.15)(0.53)(0.85)(0.79)(0.83)
Roic(1.0E-6)(3.5E-5)(0.51)(2.51)(4.17)(3.96)
Net Income Per Share(0.12)(0.22)(0.82)(1.55)(1.26)(1.32)
Cash Per Share0.007420.0061971.570.660.450.36
Pocfratio(184.22)(77.29)(10.61)(1.66)(1.79)(1.88)
Pfcf Ratio(184.22)(77.29)(10.12)(1.61)(1.78)(1.87)
Roe0.830.61(0.52)(2.44)22.7923.93
Ev To Operating Cash Flow(184.16)(77.27)(7.58)(0.97)(1.68)(1.77)
Pe Ratio(98.41)(52.54)(6.53)(0.88)(1.12)(1.17)
Return On Tangible Assets(4.28)(3.77)(0.49)(1.93)(2.04)(2.14)
Ev To Free Cash Flow(184.16)(77.27)(7.22)(0.94)(1.67)(1.76)
Earnings Yield(0.0102)(0.019)(0.15)(1.14)(0.89)(0.85)
Current Ratio0.06160.091613.452.890.750.71
Tangible Book Value Per Share(0.14)(0.37)1.570.54(0.0894)(0.085)
Graham Number0.621.365.394.721.251.8
Shareholders Equity Per Share(0.14)(0.37)1.570.64(0.0553)(0.0526)
Graham Net Net(0.16)(0.41)1.460.4(0.25)(0.24)
Price Earnings Ratio(98.41)(52.54)(6.53)(0.88)(1.12)(1.17)
Price Book Value Ratio(81.94)(32.18)3.432.13(25.48)(26.75)
Price To Operating Cash Flows Ratio(184.22)(77.29)(10.61)(1.66)(1.79)(1.88)
Price To Free Cash Flows Ratio(184.22)(77.29)(10.12)(1.61)(1.78)(1.87)
Company Equity Multiplier(0.19)(0.16)1.081.41(11.8)(11.21)
Return On Capital Employed0.830.61(0.5)(2.33)22.9624.1
Quick Ratio0.06160.038613.342.880.740.7
Cash Ratio0.02470.0070812.62.670.640.61
Price To Book Ratio(81.94)(32.18)3.432.13(25.48)(26.75)
Price Cash Flow Ratio(184.22)(77.29)(10.61)(1.66)(1.79)(1.88)
Return On Assets(4.28)(3.77)(0.49)(1.73)(1.93)(2.03)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Lucid Diagnostics is a strong investment it is important to analyze Lucid Diagnostics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lucid Diagnostics' future performance. For an informed investment choice regarding Lucid Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lucid Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lucid Diagnostics. If investors know Lucid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lucid Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.12)
Revenue Per Share
0.09
Quarterly Revenue Growth
0.497
Return On Assets
(1.01)
Return On Equity
(10.08)
The market value of Lucid Diagnostics is measured differently than its book value, which is the value of Lucid that is recorded on the company's balance sheet. Investors also form their own opinion of Lucid Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Lucid Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lucid Diagnostics' market value can be influenced by many factors that don't directly affect Lucid Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lucid Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lucid Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lucid Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.